MFHAS1
Basic information
Region (hg38): 8:8783354-8893630
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MFHAS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 18 | ||||
missense | 71 | 76 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 71 | 16 | 7 |
Variants in MFHAS1
This is a list of pathogenic ClinVar variants found in the MFHAS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-8797371-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
8-8797388-C-T | MFHAS1-related disorder | Benign (Nov 20, 2019) | ||
8-8797398-G-A | not specified | Uncertain significance (Jul 21, 2021) | ||
8-8797426-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
8-8797433-G-C | not specified | Uncertain significance (Aug 22, 2023) | ||
8-8890136-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
8-8890180-G-C | not specified | Uncertain significance (May 13, 2024) | ||
8-8890220-C-G | not specified | Uncertain significance (Mar 08, 2024) | ||
8-8890229-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
8-8890255-A-T | not specified | Uncertain significance (Aug 27, 2024) | ||
8-8890287-A-G | MFHAS1-related disorder | Likely benign (Apr 26, 2019) | ||
8-8890335-G-C | not specified | Uncertain significance (Apr 25, 2023) | ||
8-8890356-C-G | not specified | Uncertain significance (Aug 12, 2024) | ||
8-8890416-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
8-8890442-G-A | Likely benign (Dec 19, 2024) | |||
8-8890493-T-C | not specified | Uncertain significance (Sep 30, 2024) | ||
8-8890522-G-C | MFHAS1-related disorder | Likely benign (Jul 06, 2022) | ||
8-8890541-G-C | not specified | Uncertain significance (Apr 04, 2023) | ||
8-8890548-C-T | MFHAS1-related disorder | Likely benign (Jan 01, 2023) | ||
8-8890554-T-A | not specified | Uncertain significance (Jul 14, 2023) | ||
8-8890564-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
8-8890580-T-A | not specified | Uncertain significance (Feb 13, 2023) | ||
8-8890622-C-A | not specified | Uncertain significance (Jan 11, 2023) | ||
8-8890672-C-G | not specified | Uncertain significance (Jul 11, 2023) | ||
8-8890675-T-A | not specified | Uncertain significance (Feb 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MFHAS1 | protein_coding | protein_coding | ENST00000276282 | 3 | 110292 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.24e-9 | 0.987 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.94 | 757 | 621 | 1.22 | 0.0000367 | 6660 |
Missense in Polyphen | 215 | 225.79 | 0.95221 | 2573 | ||
Synonymous | -5.73 | 415 | 291 | 1.43 | 0.0000178 | 2293 |
Loss of Function | 2.36 | 19 | 33.8 | 0.562 | 0.00000202 | 338 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000168 | 0.000167 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probable GTP-binding protein (PubMed:24286120). Functions in innate immunity and more specifically the inflammatory response as a regulator of the Toll-like receptor TLR2 and TLR4 signaling pathways (PubMed:26599367, PubMed:28471450, PubMed:28609714). Negatively regulates the part of the TLR4 signaling pathway that leads to the activation of the transcription factor AP-1. By retaining the phosphatase complex PP2A into the cytoplasm, prevents the dephosphorylation of the AP- 1 subunit JUN which is required for proper activation of the transcription factor (PubMed:28609714). Both inhibits and activates the TLR2-dependent signaling pathway (PubMed:26599367). Positively regulates the TLR2 signaling pathway to activate specifically the downstream p38 and JNK MAP kinases and promote the polarization of macrophages toward the pro-inflammatory M1 phenotype (PubMed:28471450). It may also play a role in the regulation of inflammation induced by high glucose through the PKB/AKT signaling pathway (PubMed:29168081). Also involved in erythrocyte differentiation through activation of the ERK1/ERK2 signaling pathway (PubMed:23327923). {ECO:0000269|PubMed:23327923, ECO:0000269|PubMed:24286120, ECO:0000269|PubMed:26599367, ECO:0000269|PubMed:28471450, ECO:0000269|PubMed:28609714, ECO:0000269|PubMed:29168081}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving MFHAS1 may be a cause of B-cell lymphoma. Translocation t(8;14)(p23.1;q21) with a cryptic exon named '14q21 element'. The resulting fusion protein named 'chimeric MASL1' is tumorigenic in nude mice. {ECO:0000269|PubMed:14691450}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.509
- rvis_EVS
- -1.19
- rvis_percentile_EVS
- 5.89
Haploinsufficiency Scores
- pHI
- 0.105
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.410
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mfhas1
- Phenotype
Gene ontology
- Biological process
- inflammatory response;erythrocyte differentiation;negative regulation of toll-like receptor 2 signaling pathway;positive regulation of toll-like receptor 2 signaling pathway;negative regulation of toll-like receptor 4 signaling pathway;negative regulation of protein dephosphorylation;regulation of macrophage activation;innate immune response;positive regulation of JNK cascade;negative regulation of inflammatory response;positive regulation of protein kinase B signaling;positive regulation of ERK1 and ERK2 cascade;negative regulation of protein localization to nucleus;positive regulation of p38MAPK cascade
- Cellular component
- cytoplasm;mitochondrion;lysosome;cytoskeleton
- Molecular function
- protein binding;GTP binding;ubiquitin protein ligase binding;protein phosphatase 2A binding